Integrated NGS + IHC with WHO-aligned treatment guidance in 10–12 days.
Integrated NGS + IHC with WHO-aligned treatment guidance in 10–12 days.
Our laboratory integrates advanced molecular workflows, NGS
technology, and computational analytics to deliver oncology insights that
are reliable and clinically actionable.
The laboratory is designed for high-complexity molecular diagnostics, with
stringent contamination controls, optimized workflow zoning, and multi-layer quality checks to ensure reliable and reproducible results.
Validated wet-lab workflows are seamlessly integrated with advanced bioinformatics and standardized clinical interpretation frameworks.
From sample accessioning to clinical reporting —
see how precision is built into every step.
ID verification, QC checks, storage
Isolation of ccfDNA, gDNA, FFPE-derived DNA & RNA
NGS library construction
Molecular profiling & variant detection
Pipeline, annotation, classification
Report generation & validation
Identity verification, viability assessment, and pre-analytical QC
Validated enrichment and high-
sensitivity extraction protocols
Targeted NGS library construction with
rigorous QC checkpoints
High-depth sequencing with real-time
quality monitoring
Validated pipelines: alignment, calling,
annotation, AI prioritization
Evidence-based variant classification
and structured oncology reporting
From sample intake to molecular reporting, explore how our laboratory delivers precision at every stage.
A pathology professional with expertise in laboratory administration, histopathology, immunohistochemistry, and cytology. Experienced in frozen section reporting and supporting multidisciplinary tumor board discussions for accurate and timely clinical decision-making.
A seasoned healthcare executive with deep expertise in oncology, diagnostics, and precision medicine. Experienced in leading large-scale clinical programs, advancing genomic technologies, and driving strategic growth across life sciences and healthcare organizations.
Advanced molecular profiling using ctDNA and CTC
analysis with high sensitivity and clinical-grade
reproducibility.
Characterizing tumor heterogeneity at the cellular level to
capture the full landscape of genomic diversity within a
tumor.
Machine-learning enhanced variant prioritization and
panel optimization, reducing noise and surfacing clinically
significant findings.
Robust validated pipelines for variant calling, annotation,
and oncology-grade reporting against curated genomic
databases.
Digitized, traceable sample lifecycle management with
real-time monitoring and automated QC checkpoints
across all stages.
Designed for reproducibility and growth — standardized
protocols, modular infrastructure, and institutional QMS
integration.
Our lab is designed from the ground up to support high-complexity oncology diagnostics. From sample accessioning to bioinformatics interpretation, every step is optimized for accuracy, reproducibility, and scalability.
Sample accessioning, QC, storage management
Isolation, extraction, library prep workflows
NGS instrumentation with real-time monitoring
Alignment, calling, annotation pipelines
ML-assisted variant prioritization and classification
Structured reports, physician delivery, audit trail
Indicative framework — validated metrics published upon accreditation
ISO 15189 · Molecular Diagnostics
College of American Pathologists
International and national accreditation ensuring laboratory excellence and clinical-
grade reliability across all molecular assays.
NGS-based molecular assays (working days from sample receipt to report delivery)
of samples reported within committed
TAT window
of samples clear all quality checkpoints
Validated across target oncology panels using orthogonal confirmation methods.
Variant allele frequency detection limits optimized per assay type and clinical context.
High-depth somatic profiling, SNV ·
INDEL · CNV
Ultra-deep sequencing for ctDNA at low VAF
All molecular findings are classified and reported in alignment with internationally
recognized evidence-based guidelines.
Variants tiered according to clinical significance and therapeutic actionability per
standardized classification frameworks.
Independent QC stages across the full
assay lifecycle
Physically separated workflow zones
with unidirectional flow
Low repeat rate reflects robust pre-analytical controls, library optimization, and run
quality monitoring. Continuously tracked under the laboratory QMS.
Metrics are assay- and indication-dependent and are continuously monitored as part of the laboratory quality management system.
Values represent validated performance ranges and may vary by panel, sample type, and clinical context.